CIK 0002007919 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990613523
- Phone
- (858) 795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $6,347,357
- in 7 filings
- Open-market sales, last 90 days
- $279,010
- in 2 filings
Net +$6,068,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-30 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-05-30 | MANHARD KIMBERLY Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-05-30 | Lappe Mark Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2024-05-30 | Kayyem Jon Faiz Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-05-30 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-05-30 | Eckelman Brendan P. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2024-05-30 | Deck Kelly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2024-05-29 | Inhibrx, Inc. 10% owner | Other disposition | −13,316,140 | 1,157,926 | ||
| 2024-05-29 | Lappe Mark Chief Executive Officer | Grant or award | +621,548 | 621,548 | ||
| 2024-05-29 | Lappe Mark Chief Executive Officer | Grant or award | +125,000 | 125,000 | ||
| 2024-05-29 | Lappe Mark Chief Executive Officer | Grant or award | +14,865 | 14,865 | ||
| 2024-05-29 | Kayyem Jon Faiz Director | Grant or award | +806,075 | 806,075 | ||
| 2024-05-29 | Kayyem Jon Faiz Director | Grant or award | +6,250 | 6,250 | ||
| 2024-05-29 | Kayyem Jon Faiz Director | Grant or award | +6,250 | 6,250 | ||
| 2024-05-29 | FORSYTH DOUGLAS Director | Grant or award | +149,564 | 149,564 | ||
| 2024-05-29 | Eckelman Brendan P. Chief Scientific Officer | Grant or award | +433,888 | 433,888 | ||
| 2024-05-29 | Eckelman Brendan P. Chief Scientific Officer | Grant or award | +40,000 | 40,000 | ||
| 2024-05-29 | Eckelman Brendan P. Chief Scientific Officer | Grant or award | +40,000 | 40,000 |
Page 5 of 5 · 98 trades